StockDriftsStockDriftsTop 50 Pavaki Capital Management LLC Holdings
| Stock | Company | % Port. | Shares | Value | Activity | Ownership | Avg. Cost | Date |
|---|---|---|---|---|---|---|---|---|
| CVX | CHEVRON CORP NEW | 9.16% | 97.0K | $16.1M | +30.20%(+22.50K) | $181.11(+7.63%) | 2026-06-30 | |
| MIST | MILESTONE PHARMACEUTICALS IN | 6.92% | 9.07M | $12.2M | +0.06%(+5.00K) | $1.98(-36.76%) | 2026-06-30 | |
| INTU | INTUIT | 5.74% | 38.6K | $10.1M | new | $345.01(-3.96%) | 2026-06-30 | |
| QCOM | QUALCOMM INC | 5.16% | 49.0K | $9.1M | new | $155.93(+4.96%) | 2026-06-30 | |
| B | BARRICK MNG CORP | 4.64% | 221.5K | $8.1M | +0.00%(+0) | $38.66(+5.00%) | 2026-06-30 | |
| TXT | TEXTRON INC | 4.41% | 84.3K | $7.7M | +97.42%(+41.60K) | $87.32(+2.28%) | 2026-06-30 | |
| REGN | REGENERON PHARMACEUTICALS | 3.52% | 9.9K | $6.2M | +25.32%(+2.00K) | $670.98(+21.17%) | 2026-06-30 | |
| NVDA | NVIDIA CORPORATION | 2.96% | 26.0K | $5.2M | +62.50%(+10.00K) | $185.04(+19.14%) | 2026-06-30 | |
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | 2.79% | 187.0K | $4.9M | +0.00%(+0) | $23.95(+9.40%) | 2026-06-30 | |
| SPRY | SILVERBACK THERAPEUTICS INC | 2.65% | 579.6K | $4.6M | +0.59%(+3.40K) | $10.83(-45.81%) | 2026-06-30 |
| Performance Metric | 3-Year Annualized | 3-Year Cumulative | 5-Year Annualized | 5-Year Cumulative | Since First Filing (2 quarters) |
|---|---|---|---|---|---|
| Top 20 Holdings Weighted | — | — | — | — | -5.11% |
| Top 20 Holdings Unweighted | — | — | — | — | +10.59% |
Pavaki Capital Management LLC reports $286.82M in US-listed equity holdings across 132 positions in its most recent 13F filing. Its largest disclosed positions are CVX (9.2%), MIST (6.9%) and INTU (5.7%). The top 20 holdings account for 65.76% of reported assets. Its disclosed equity book has returned -5.11% cumulatively over 2 quarters. Figures reflect the Q2 2026 filing.
Portfolio changes
Every reported change this quarter, grouped by direction. The signal is in the rotation, not any single trade.
Sign up free to track Pavaki Capital Management LLC, compare funds side by side, and get alerts the moment positions change.
Holdings on this page are parsed from Pavaki Capital Management LLC’s Form 13F filings with the U.S. Securities and Exchange Commission (CIK 2143027). View Pavaki Capital Management LLC’s 13F filings on SEC